🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Angelina T. Regua

The University of Texas Health Science Center

ORCID: 0000-0003-2595-8242

Also affiliated with The University of Texas Health Science Center at Houston

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases”.

Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases

Cancer Letters(2022)10.1016/j.canlet.2022.215726

N/A

0.617DataRank · unranked

60 citations

Grace L. Wong, Noah R. Aguayo, Daniel Doheny, Dongqin Zhu, Angelina T. Regua +10 more

TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers

Cancers(2021)10.3390/cancers13102340

N/A

0.457DataRank · unranked

20 citations

Noah R. Aguayo, Sara Abu Jalboush, Daniel Doheny, Sara G. Manore, Dongqin Zhu +13 more

Antibody-Drug Conjugates for the Treatment of HER2-Positive Breast Cancer

Genes(2022)10.3390/genes13112065

N/A

0DataRank · unranked

97 citations

Sara G. Manore, Angelina T. Regua, Hui‐Wen Lo, Mariana K. Najjar

NEDD4 degrades TUSC2 to promote glioblastoma progression

Cancer Letters(2022)10.1016/j.canlet.2022.01.029

N/A

0DataRank · unranked

14 citations

Austin Arrigo, Dongqin Zhu, Richard L. Carpenter, Sherona Sirkisoon, Daniel Doheny +11 more

Tumor Suppressor Candidate 2 (TUSC2): Discovery, Functions, and Cancer Therapy

Cancers(2023)10.3390/cancers15092455

N/A

0DataRank · unranked

6 citations

Angelina T. Regua, Mariana K. Najjar, Hui‐Wen Lo, Austin Arrigo

Dual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers

Cancer Letters(2024)10.1016/j.canlet.2024.217023

N/A

0DataRank · unranked

17 citations

Shivani Bindal, Mariana K. Najjar, Chuling Zhuang, Munazza S. Khan, Austin Arrigo +6 more

Transgenic mouse models of breast cancer

Cancer Letters(2021)10.1016/j.canlet.2021.05.027

N/A

0DataRank · unranked

26 citations

Austin Arrigo, Daniel Doheny, Grace L. Wong, Hui‐Wen Lo, Angelina T. Regua

Correction: Regua et al. TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers. Cancers 2021, 13, 2340

Cancers(2024)10.3390/cancers16193409

N/A

0DataRank · unranked

0 citations

Noah R. Aguayo, Sara Abu Jalboush, Daniel Doheny, Sara G. Manore, Dongqin Zhu +13 more

RET signaling pathway and RET inhibitors in human cancer

Frontiers in Oncology(2022)10.3389/fonc.2022.932353

N/A

0DataRank · unranked

98 citations

Mariana K. Najjar, Hui‐Wen Lo, Angelina T. Regua